The specificity of the enzyme(s) catalyzing the covalent link between the hydroxyl side-chains of serine or threonine and the sugar moiety GalNAc is unknown. Pattern recognition by artificial neural networks and weight matrix algorithms was performed to determine the exact position of in vivo O-linked GalNAc glycosylated serine and threonine residues from the primary sequence exclusively. The acceptor sequence context for O-glycosylation of serine was found to differ from that of threonine and the two types were therefore treated separately. The context of the sites showed a high abundance of proline, serine and threonine extending far beyond the previously reported region covering positions -4 through +4 relative to the glycosylated residue. The Oglycosylation sites were found to cluster and to have a high abundance in the amino-terminal part of the protein. The sites were also found to have an increased preference for three different classes of -turns. No simple consensus like rule could be deduced for the complex glycosylation sequence acceptor patterns. The neural networks were trained on the hitherto largest data material consisting of 48 carefully examined mammalian glycoproteins comprising 264 O-glycosylation sites. For detection neural network algorithms were much more reliable than weight matrices.
exclusively. The acceptor sequence context for O-glycosylation of serine was found to differ from that of threonine and the two types were therefore treated separately. The context of the sites showed a high abundance of proline, serine and threonine extending far beyond the previously reported region covering positions -4 through +4 relative to the glycosylated residue. The Oglycosylation sites were found to cluster and to have a high abundance in the amino-terminal part of the protein. The sites were also found to have an increased preference for three different classes of -turns. No simple consensus like rule could be deduced for the complex glycosylation sequence acceptor patterns. The neural networks were trained on the hitherto largest data material consisting of 48 carefully examined mammalian glycoproteins comprising 264 O-glycosylation sites. For detection neural network algorithms were much more reliable than weight matrices.
The networks correctly found 60-95% of the O-glycosylated serine/threonine residues and 89-97% of the non-glycosylated residues in two independent test sets of known glycoproteins. A computer server using E-mail for prediction of O-glycosylation sites has been implemented and made publicly available.
INTRODUCTION
Glycosylation serves a wide variety of functions in biology [1] and is involved in recognition [2] , oncogenesis [3, 4] , and development [5] . Experimental biochemical analysis of potential Oglycosylation sites in glycoproteins at serine or threonine residues is difficult and time consuming, since it requires solid phase Edman degradation [6] . The knowledge of the structure and function of O-glycosylated proteins could be improved if the exact location of their carbohydrate part could be deduced directly from the primary sequence. Computational prediction may therefore lead to a better understanding of O-glycosylated proteins in general.
The sequence specificities of N-and O-linked glycosylation differ markedly. For N-linked glycosylation, the specificity of the enzyme can be formulated as the consensus triplet sequence Asn-X-Ser/Thr, where X can be any residue except proline [7] . Not all consensus triplets are actually glycosylated [8] , but all known N-linked glycosylation sites are found within this triplet sequence [9] . This makes prediction of N-linked glycosylation from the primary sequence less problematic.
The situation is far more complex for O-linked glycosylation since at least seven classes of O-linked glycosylation can be defined:
Mucin type, where an N-acetylgalactosamine is -1 linked to the side chain of serine or threonine residues in secreted or membrane bound glycoproteins (for recent reviews see [10, 11] ).
Intra-cellular type, where a single N-acetylglycosamine is covalently linked to serine or threonine in nucleoplasmic and cytoplasmic glycoproteins (for a recent review see [12] ).
Proteoglycan type, where a xylose core (Gal-Gal-Xyl) is linked to serine in proteoglycan glycoproteins [13, 14] .
Collagen type, where galactose is linked to hydroxy-lysine in collagen [15] .
Clotting factor type, where either fucose or a glycose core (Xyl-Glc or Xyl-Xyl-Glc) is linked to serine in factor VII and IX, protein Z and others [16, 17] .
Fungal type, where mannose is linked to serine or threonine in yeast and fungal glycoproteins [18] .
Plant type, where arabinose is linked to hydroxy-proline and galactose to serine in plant glycoproteins [19] .
The enzymes initiating the biosynthesis of O-linked glycosylation by transfer of monosaccharides to specific acceptor residues are type specific. Since it is likely that acceptor specificities of these glycosyl-transferases differ [6] , the present analysis has been limited to the first most common group.
Mucin type O-linked glycosylation has no unique consensus acceptor sequence [20, 21] . This becomes apparent by inspection of the mucin type O-glycosylated sequences in Table 1 . However, a few rules of thumb have been formulated: Proline occurs at increased frequency at positions -1 and +3 relative to the glycosylation site as found by Wilson et al. [20] . Glycoproteins are however also rich in this motif at non-glycosylated sites [20] .
Elhammer et al. extended this by in vitro experiments using bovine colostrum transferase and matrix statistics on a data set of 196 glycosylation sites [22] . They found that a high abundance of not only proline, but also serine and threonine at all positions from -4 to +4 favoured glycosylation.
Gooley et al. [23] have proposed the sequence motif X-Pro-X-X, where one X only is a glycosylated threonine. However, O-glycosylation of threonine which is not associated with proline also occurs [23] .
Pisano et al. [24] have suggested three tetrapeptide sequence motifs for O-glycosylation of threonine: X-Pro-X-X, Thr(g)-X-X-X (where Thr(g) and one X only are glycosylated threonine residues), and, X-X-Thr(g)-X, (where X represents lysine or arginine). For serine the proposed tetrapeptide sequence motif is: Ser(g)-X-X-X, (where X represents one glycosylated serine residue).
These motifs account for all glycosylations within glycophorin A [24] and 16 out of 18 sites in bovine casein [6] . However these motifs are also quite frequent at non-glycosylated sites which limits their predictive value (see below).
O'Connell et al. found that positions -6, -1 and +3 were of particular significance [25] . By in vitro glycosylation of model-peptides from von Willebrand factor using bovine colostrum GalNActransferase, O'Connell et al. [26] found that amino acid substitutions with alanine, proline, isoleucine, asparagine or glutamic acid at positions +3,-2,-3 reduced O-glycosylation, as did substitution with a charged residue at position -1. O'Connell et al. could not glycosylate a serine residue in a peptide derived from the in vivo glycosylated human erythropoietin. If serine was substituted with threonine, the peptide was glycosylated.
From these findings O'Connell et al. speculated that separate serine-and threonine-specific GalNAc-transferases may exist. However, GalNAc-transferases from bovine colostrum [22] and porcine submaxillary glands [27] were recently shown to be able to glycosylate serine as well as threonine residues.
Using a purified GalNAc-transferase from porcine submaxillary glands on model peptides from erythropoietin or porcine mucin, Wang et al. found that the residues adjacent to the serine or threonine strongly influenced the glycosylation [27] . Testing the effects of all possible substitutions at all sites, by synthesising putative acceptor peptides and testing their activity with a purified GalNAc-transferase, would be a formidable task [27] . This motivates the development of a sequence based tool to point out likely acceptor peptides.
Originally our aim was to use a modified version of a recently developed statistical method for analyzing broad specificities of enzymes [28] . The goal was to predict from the primary sequence alone, whether specific serine and threonine residues in a glycoprotein are O-glycosylated or not. This matrix method, however, used the sequence context around glycosylated residues only. Information in sequence contexts of non-glycosylated serines and threonines is consequently lost.
In addition we have therefore applied artificial neural network algorithms, which have recently been used with success in predicting protein secondary structure from primary sequence [29, 30, 31, 32, 33, 34] , and human mRNA donor and acceptor sites from the pre-mRNA sequence [35] . Neural networks are capable of including the negative information from the non-glycosylated sequences and can reproduce even highly complex and non-linear sequence patterns [36] .
Thus, two independent statistical tools were applied, together with a carefully selected data set of in vivo mucin type O-glycosylated proteins. The validity of the prediction methods was assessed by test on two different data sets of novel glycoproteins with known sequence and glycosylation assignments, which were not used when generating the methods.
MATERIALS AND METHODS

Sequence data selection criteria
All proteins with a carbohydrate assigned to either serine or threonine were extracted from the 1994 versions of SWISS-PROT (Rel. 29) and PIR (Rel. 41.00) databases [37, 38] .
In SWISS-PROT all protein entries with a CARBOHYD assignment for a serine or threonine in the feature This crude extract constituted 221 glycoproteins with known sequence and O-glycosylation sites.
In the case of copies of the same sequence only one was kept. All non-mammalian glycoproteins were excluded. Furthermore, all proteins which did not have a GalNAc sugar moiety linked to serine or threonine were excluded. Nuclear and cytoplasmic glycoproteins, coagulation factors and proteoglycans were thereby removed from the data set.
Importantly, all examples were extensively checked for sequence and assignment errors by consulting the original references listed in Table 1 . The errors found can be divided in two groups.
One group comprises sites described in the literature as being glycosylated, but with no assignments in the databases. Another group contains sites in the databases which could not be verified by the original references. A small group consists of glycoproteins which have been revised recently.
One example is Glycophorin A, which earlier was thought to contain 15 O-glycosylation sites [39] and do so in PIR (entry GFHUE). However, glycophorin A has recently been revised to contain 16 O-glycosylation sites [24] .
A list of the glycoprotein entries, which were revised according to the literature, is given in Table   2 .
In general the information from the databases was reliable for glycosylated residues, but caution should be taken before concluding that a given serine or threonine was not glycosylated if not listed in the feature table as being so. An example is the leukosialin family where the two SWISS-PROT entries: LEUK_HUMAN and LEUK_RAT, have 25 and 24 CARBOHYD assignments respectively, but probably contain 80 O-glycosylation sites [2] . In order to eliminate sites which are O-glycosylated, but not assigned in the database, we therefore presented these proteins as the smaller fragments used during sequencing.
Though it still is debated whether the initial addition of GalNAc to the peptide is located late in the transitional elements of ER, or in the cis-golgi cisternae [11, 10] , it is generally believed that O-glycosylation is a post-translational event. The signal peptide, transmembrane and cytoplasmic domains of membrane proteins will consequently never be presented to the luminally located GalNActransferase. Therefore the serines and threonines in these domains can never be mucin-type Oglycosylated. The glycoprotein sequences used were truncated accordingly, in order not to dilute the true non-glycosylated sequence contexts with irrelevant information.
A few glycosylation sites in recently published glycoproteins were extracted directly from the literature. The corresponding sequences were found in the database and assigned according to the reference ( Table 2 ).
In order not to bias the data set with identical sequence contexts, the sequence similarity between the glycosylation sites was quantified by computing the number of identical residues between all pairs in a 9 residue window. Examples with identical residues from position -4 to +4 were excluded.
Finally, all non-glycosylated sequence windows were compared with the glycosylated sequences; no conflicts were found.
The final yield was 48 unique mammalian glycoproteins containing 161 in vivo O-glycosylated threonine residues, 103 in vivo O-glycosylated serine residues and 2065 non-glycosylated threonine/serine residues. This data set, which to our knowledge is the largest presented to date, was the empirical basis for the analysis.
Similarity within the glycosylated sequences
The predictive performance of any data driven algorithm will depend on the degree of similarity between the test sequence, and the sequences used when developing the method. Therefore, in order to compare our predictive performance with the earlier method of Elhammer et al. [22] , we compared the degree of similarity within our data set to the degree of similarity within the data used by Elhammer et al.. Comparing the complete sequences is not relevant, since it is the local similarity around glycosylated sites, which is of primary importance in determining whether or not the sites are glycosylated. Instead, we counted the number of identical residues around glycosylation sites in the 9 residue windows used by Elhammer et al.. This local similarity was computed for glycosylated serine and threonine sequence windows in our data set and compared to the data set of Elhammer et al.. The majority of sites had 4 identical residues in a 9 residue window, see Figure 1 . Around 2% of the glycosylated threonine windows in the data set of Elhammer were identical biasing this data set slightly. Otherwise the similarity distributions are comparable.
Selection of independent test sets
In order to test the accuracy of our prediction schemes, 18 of the most recently published Oglycosylated proteins, which were not included in the data used by Elhammer et al., were selected as test proteins. These were used neither during training of the networks, nor during calculation of the weights of the matrices, and were consequently unknown to both methods. The test set was divided into two subsets with 14 proteins (34 sites) with low similarity to the training set, and a set of 4 proteins (36 sites) with high similarity to the training set, see Table 1 . This separation was made in order to determine the degree of prediction accuracy that could be expected on a given novel protein sequence.
Quantification of sequence information content
When a large set of sequences is aligned, the Shannon information measure [40] can be used to quantify the randomness of each column. The information content was computed by the formula 
Neural network algorithms
We used a data driven neural network algorithm, with one layer of hidden units, and adjusted the weights according to the method described by Rumelhart et al. [42] . Hence each neuron (unit) besides those in the input layer, calculates a weighted sum of its inputs and passes this sum through a sigmoidal function to produce the output
w n I n ? t); (2) where N is the number of neurons in a layer, I n the nth input to the neuron and w n the weight of this input. was the sigmoidal function (x) = 1=(1 + exp(?x)), and t its threshold.
We trained the network on experimentally determined relations between amino acid compositions surrounding glycosylated and non-glycosylated serine and threonine residues. Using a steepest descent method, the purpose of the training is to adjust the weights and thresholds in the network to quantitatively minimize the error between the prediction and the experimentally determined assignment.
Each amino acid was represented as a binary string of 21 bits using 21 input neurons.
Alanine and cysteine were, for example, represented as 10000000000000000000 and 01000000000000000000, respectively.
We used a symmetric input window of amino acids, ranging from 3 amino acids (covering the two amino acids flanking the serine/threonine site) to 49 (24 amino acids on each side of the glycosylated serine/threonine). Neural networks with 0 to 15 hidden units were evaluated for prediction performance. A small network with a window of 3 residues, and with three hidden units, is shown in Figure 2 . Other details of the training procedure may be found elsewhere [35] .
To find the best network we tested the performance of different network architectures (different numbers of units in the input and in the hidden layer) by training on 34 glycosylated proteins as described above and testing the performance of the network on the remaining proteins, using the correlation coefficient C [43, 35] as quality measure. This measure is more relevant than merely measuring the percentage of correctly predicted residues, as approximately 90% of the residues are non-glycosylated. Hence a network which classifies all threonines or serines as non-glycosylated will be 90% correct, but not of much use.
In this equation P x is the number of true positives (experimentally determined glycosylated, predicted glycosylated), N x the number of true negatives (experimentally non-glycosylated, predicted non-glycosylated), P f x the number of false positives (experimentally non-glycosylated, predicted glycosylated), and N f x the number of false negatives (experimentally glycosylated, predicted nonglycosylated). The correlation coefficients were obtained as the average over 10 networks with different initialization of the weights.
Matrix method
A matrix method was also used to predict glycosylation sites. We investigated different revisions of the method developed by Poorman et al. [28] , and used by Elhammer et al. [22] are the total number of amino acids i at site j and the number at glycosylated sites, respectively. The total number of amino acids and glycosylated sites are given by N T and N T P , respectively. The predicted probability h that a given site is glycosylated is calculated (using the relevant value of i for each j) as ; (4) where W is the size of the window, q i;j the probability that the frequency of amino acid i at site j at all sites and the corresponding frequency at the glycosylated sites are equal. The probabilities q i;j are calculated by the library routine betai [44] taking as the standardized normal deviate [45] : We revised the method used by Elhammer et al. [22] in three ways: (a) We weighted the relative frequencies by the probability that the difference is in fact genuine. This was done because some of the frequencies calculated were based on very few examples, and random fluctuations in the number of observed examples could thus bias the method. Poorman et al. [28] 
RESULTS
Mucin type O-linked glycosylation is clustered and frequent near the amino-terminal
Sequence logos of the glycosylated sequences were prepared ad modus Schneider [41] , see Figure 3 .
The logos reflect the bias in the distribution of residues surrounding glycosylation sites. The size of the symbols reflect the patterns of in vivo acceptor specificity of the GalNAc-transferase(s) catalyzing O-linked glycosylation. The logos demonstrate that the high abundance of threonine, serine, and proline in the context of O-glycosylation extends upstream beyond position -4 and downstream beyond position +4, as earlier reported [22] . This abundance pattern was specific for glycosylated sites, since it was not found in the non-glycosylated sequences. The abundance of proline at positions -1 and +3, originally reported by Wilson et al. [20] , is especially evident for glycosylated threonine residues. It may be observed that the glycosylation signal for threonine differs from the signal of serine glycosylation.
The O-glycosylation signal is seen to be considerably less well defined than the consensus triplet of N-linked glycosylation. Certain residues are rarely seen in close proximity of the glycosylation sites. We never found cysteine in position -2 to +2, nor tryptophane in position -1 or +1 relative to glycosylated threonines, although they were found frequently in the non-glycosylated sequences.
This indicates that O-glycosylation at threonine is disfavoured in proximity to disulfide bridges and very large side chains, possibly as a cause of steric hindrance. Methionine, aspartic acid and asparagine were also very rarely found juxtaposed to the O-glycosylated residue.
We also computed the distance between the sites in order to estimate the degree of clustering. As shown in Figure 4 more than 25% of the sites have another O-glycosylation site as neighbour, and for 15% of the sites only one residue is interposed. We found that 25% of the sites were located within the first 10% of the protein length, meaning that O-glycosylation is abundant near the amino-terminal of the protein.
Physico-chemical properties of O-glycosylation sites
We examined the difference in averaged hydrophobicity, side chain size, and charge between the O-glycosylated versus the non-glycosylated sequences, see Figure 5 .
On average the hydrophobicity of the glycosylated sites was lower than for the non-glycosylated sites, which confirms that O-glycosylation is unambiguously found on the protein surface. The side chain size was generally smaller in the glycosylated sites, probably due to steric hindrance of the GalNAc-transferase by very large side chains.
The average values of positive charge (arginine, histidine, and leucine) was lower for the gly- 
Conformation preference of O-glycosylation sites
We examined the secondary structure preference of glycosylated sequences compared to nonglycosylated sequences. The -helix preference was lower for the glycosylated sequences compared to the non-glycosylated, as was also the case for -strand (data not shown). However, the reverseturn preference was clearly enhanced for the glycosylated sequences. We therefore examined the preference for several different types of turns, see Figure 6 .
The analysis was based on the turn preferences of different amino acids computed in [47, 48] .
They used the classification of Richardson [49] , who defined seven categories: type I, II, I', II', VIa, VIb and a miscellaneous category IV. Wilmot et al. [47] also defined an additional class VIII.
However, they had only sufficient data to perform a statistical analysis on type I and II turns. The remaining turns were combined to give a non-specific turn data set (other turns). We observed an increased preference of the glycosylated sequences for all these three turn categories when compared to the non-glycosylated sequences. The most prominent difference was observed for the class I and for other turns in which the most prevalent turn types were IV and VIII.
We conclude that there is a significant difference in the secondary structure preference of the glycosylated sites versus the non-glycosylated. Glycosylated sequences can be characterized as having low preference for -helix and -strand and high preference for reverse turns.
Predictive performance of neural network algorithms
The predictive performance of the networks was strongly dependent on the window size, as shown in Figure 7 . We observed correlations at a longer range far beyond what has been reported pr eviously.
The other main observation was that a separation of the threonine and serine examples was beneficial as an increase in performance occurred when predictions were carried out separately.
For threonine, the performance variation as function of window size on the low similarity test set is shown in Figure 7 . The optimal window size was 17 residues with 8 residues symmetrically on each side of the glycosylated threonine. This indicates that correlations exist between certain amino acids eight residues away from the glycosylated residue. This is also indicated by the high abundance of serine, threonine, proline and alanine at these distances ( Figure 3 ). In the work of Elhammer et al. an optimal window size of 9 residues was found; in Figure 7 this is clearly seen to be suboptimal.
The problem of predicting glycosylated threonines is not highly non-linear, as networks with 0, 3, 5, 7, 9, 11, 13 hidden units have comparable performance (data not shown). A network with 5 hidden units was slightly better than the other configurations. With this network architecture we obtained a maximal correlation coefficient of 0.42, corresponding to finding 67% of the glycosylated threonines and 88% of the non-glycosylated threonines in the low similarity test set (Table 3) . On this novel test set the matrix method of Elhammer et al. [22] had a lower correlation coefficient of 0.35, and percentages of 59% and 88%, respectively. For the high similarity test set the maximal network correlation coefficient was 0.88, corresponding to finding 95% of the glycosylated threonines and 96% of the non-glycosylated threonines. For these values the matrix method of Elhammer gave 0.73, 85%, 93%, respectively.
For serine, a window of 15 residues (7 on each side of the glycosylated serine) gave the optimal correlation coefficient. However, a window of 39 residues was nearly as good. This indicates the existence of correlations between distant residues in the sequence, and reaffirms that the acceptor sequence pattern for serine differs from that of threonine. Table 3 reports the performance values (C, percentages of correctly predicted glycosylated residues and non-glycosylated residues) on the low similarity test set: 0.33, 60%, 97%, respectively.
The Elhammer matrix gave 0.14, 60%, 84%. On the high similarity test set we obtained 0.70, 75%, 97%, respectively; and (Elhammer) 0.63, 75%, 95%.
The problem of predicting glycosylated serine residues is more non-linear, as networks with hidden units performed significantly better than linear networks without hidden units. The linear network with 0 hidden units had a performance comparable to the matrix method of Elhammer et al.
Overall, it was more difficult to predict glycosylated serines than glycosylated threonines. This could either reflect the higher degree of non-linearity in the serine prediction, or it could be due to the poorer statistical representation of glycosylated serines compared to threonines (103 sites versus 161 sites). For both cases the window size of 9 residues used by Elhammer et al. [22] is seen to be suboptimal for the predictive performance ( Figure 7 ).
Prediction performance of weight matrix algorithms
For the matrices, increased performance was also found when treating serine and threonine residues separately. Curves of similar shape as in Figure 7 , were obtained with the matrix method, albeit with a somewhat lowered performance in comparison to the networks equipped with hidden units.
This means that we have confirmed the long range correlations found especially for serine by two independent methods.
Besides varying the window size, we investigated a number of other possible ways of increasing the performance of the method, but none of the variations described in Materials and Methods led to a substantial increase in performance.
Limited predictive performance of proposed motifs
The proposed motifs of Gooley et al. [23] and Pisano et al. [24] fit a reasonable fraction of the glycosylated residues in the 48 O-glycosylated proteins (Table 4) , but the predictive value of the motifs is limited since the motifs are also found at many non-glycosylated sites. A maximal correlation coefficient of 0.27 was found for the first motif in Table 4 , X-Pro-X-X. No other motif gave better results. This is well below the performance level of Elhammer's method.
DISCUSSION
If, as proposed recently [6] , more than one GalNAc-transferase exists with different but overlapping specificities, how can one be sure that only one enzyme with a well defined specificity is isolated during the purification process? This may explain the diversity of findings using in vitro glycosylation of synthetic model peptides with purified GalNAc-transferases.
All O-linked glycosylations have been predicted to be located within -turns either in the second or the third position of the turn [50] . Synthetic peptides, which are O-glycosylated in vitro, adopt aturn as shown by circular dichroism by Hollosi et al. [51] . The specificity of the GalNAc-transferase could therefore be defined as the amino acid sequence which is able to adopt and/or stabilize an exposed -turn. The earlier proposed motifs [23, 24] account for a fraction of especially O-glycosylated threonines, but are non-specific as they are also present at many non-glycosylated sites, thus limiting their predictive value.
Analyzing 264 O-glycosylation sites, we found a high frequency of serine, threonine, proline, alanine and valine extending up to twenty residues upstream and downstream relative to the Oglycosylated threonine or serine. This extends the result of Elhammer et al. [22] who found an increased frequency of serine, threonine and proline in the region covering positions -4 through +4.
This does not mean that proline, serine and threonine favour glycosylation at all these positions, but probably reflects that these residues have different positional preference in the various types of reverse turns. When all glycosylated sequences are aligned relative to the glycosylated residue, proline, serine and threonine will be abundant on nearly all positions, as shown in Figure 3 .
We have shown that the acceptor sequence context of glycosylated serine residues is much harder to recognize computationally than that of threonine residues. Using neural networks we have shown that the former problem is non-linear, while the latter is linearly separable. This is consistent with the experimental difficulties in glycosylation of serine sites as compared to threonine sites, e.g.
Elhammer et al. found that bovine GalNAc-transferase glycosylates threonine 35 times faster than serine [22] .
In agreement with Wilson et al. [20] we found an increased frequency of proline at position -1 and +3 relative to both glycosylated serine and threonine residues. However, for glycosylated serine residues, positions +1,-8 and -9 also had a significantly increased frequency of proline, threonine and serine. One may speculate that proline in positions -1 and +1 functionally acts as a 'gating' residue favouring O-glycosylation and inhibiting N-glycosylation, because it contradicts the extended consensus sequence Asn-X-Ser/Thr-X, where X can be any residue except proline.
The glycosylation patterns can, with advantage, be recognized using neural networks and a large and verified data base of in vivo O-glycosylated proteins. Using the neural network technique we were able to predict the position of 60-75% of the glycosylated serines and 67-95% of the glycosylated threonines, exclusively from the primary sequence. This is better than any other available method.
A key problem is the presence of many buried negative sites in the data set, which would probably be glycosylated if they were exposed on the surface of the protein and were thereby accessible to the GalNAc-transferase. Adding a reliable prediction of surface exposure and of -turn positioning will presumably lead to enhanced prediction performance.
E-mail server publicly available
Sequences in single letter amino acid code of 80 characters per line should be be put into a file and mailed to the internet address NetOglyc@cbs.dth.dk. The prediction of the networks will be returned immediately.
Figure legends Corrected and revised glycoproteins in the database. Table 3 . Predictive performance of the proposed sequence motifs for GalNAc-transferase. The occurrences of the motifs at glycosylated sites (Thr/Ser-glyc) and non-glycosylated (Thr/Ser non-glyc) sites were counted in the complete data set of 48 O-glycosylated proteins. Some sites fit more than one motif. TRSPN S TAWPL  RSPNS T AWPLS  TAWPL S LEPDP  DPGMA S ASTTM  GMASA S TTMHT  MASAS T TMHTT  ASAST T MHTTT  STTMH T TTIAE  TTMHT T TIAEP  TMHTT T 
-SST T GVAMH GVAMH T STSSS VAMHT S TSSSV AMHTS T SSSVT MHTST S SSVTK TSSSV T KSYIS SSVTK S YISSQ TKSYI S SQTND YISSQ T NDTHK THKRD T YAATP DTYAA T PRAHE RAHEV S EISVR EVSEI S VRTVY EISVR T VYPPE A05273 (S)
IPHQI S SKLPT Table 4 Proposed Sequence Motif (reference) Thr-glyc Thr non-glyc X-Pro-X-X, where one X is a glycosylated threonine [23] 79 161 Thr(g)-X-X-X, where one X and Thr(g) is a glycosylated threonine [24] 36 224 X-X-Thr(g)-X, where one X is either arginine/lysine [24] 18 191 Proposed Sequence Motif (reference) Ser-glyc Ser non-glyc Ser(g)-X-X-X, where Ser(g) is a glycosylated serine and X is a serine [24] 46 327 Figure 1 . 
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Entry O-site sequence Ref. Position 54321-0+12345 LEUK_HUMAN (S) ----S T TAVQT [60] Leukosialin ---ST T AVQTP -human
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ALC1_HUMAN (S) PCPVP S TPPTP [61] Ig alpha-1 chain TPPTP S PSTPP -human. PTPSP S TPPTP TPPTP S PSCCH PTPSP S CCHPR ALC_MOUSE (S) LDVNC S GPTPP [62] Ig Alpha chain C -mouse DHHU (P) PKAQA S SVPTA [63] Ig delta KAQAS S VPTAQ chain C ASSVP T AQPQA -human SLAKA T TAPAT LAKAT T APATT TTAPA T TRNTG TAPAT T RNTGR FQHUGM (P) -APAR S PSPST [64] granulocyte-macrophage PARSP S PSTQP colony-stimulating RSPSP S TQPWE -human SPSPS T QPWEH EPO_HUMAN (S) PPDAA S AAPLR [65] erythropoietin -human KTHUB(P) QDSSS S KAPPP [66, 67] choriogonadotropin KAPPP S LPSPS beta chain SLPSP S RLPGP -human RLPGP S DTPIL CTHUP(P) DEQPL T ENPRK [68, 69] corticotropin -human A16604 (S) KIIIP T INTIA [70] kappa casein ATVEP T PAPAT -human TPAPA T EPTVD PATEP T VDSVV VDSVV T PEATT TPEAT T ESIIT TESII T STPET SIITS T PETPT TVAVP T TSA-- VAVPT T SA--- CASB_BOVIN (S) FAQTQ S LVYPF [71] beta casein PPLTQ T PVVVP -bovine LSLSQ S KVLPV PLBO (P) ESSPL S TERMD [72] plasmin -bovine Entry O-site sequence Ref. Position 54321-0+12345 PLHU (P) EELAP T APPEL [72] plasmin -human PLMN_PIG (S) TTPPP T SGPTY [72] plasmin -porcine ICHU2 (P) ---AP T SSSTK [73] interleukin 2 -human KGHUH1 (P) IKEET T VSPPH [74] kininogen HMW I SEDST T PSAQT -human QTQEK T EGPTP KTEGP T PIPSL AKPGV T VTFSD SDLIA T MMPPI MMPPI S PAPIQ IPDIQ T DPNGL SEINP T TQMKE KNH1_BOVIN (S) EGPVV T AQYEC [75] kininogen MKTEG S TTVSL HMW I -bovin KTEGS T TVSLP TEGST T VSLPH VSLPH S AMSPV EDSTT S SAQTQ QTQEK T EETTL KTEET T LSSLA PGVAI T FPDFQ SDLIA T VMPNT TVMPN T LPPHT IPDIQ T EPNSL A29789 (S) -----S SVPGE [76] mucin ----S S VPGES (fragment) SVPGE S ATPQQ -sheep
PGESA T PQQPG QPGAL S ESTTQ GALSE S TTQLP ALSES T TQLPG LSEST T QLPGV QLPGV T GTSAV PGVTG T SAVTG GVTGT S AVTGS GTSAV T GSEPG SAVTG S EPGLP EPGLP S TGVSG PGLPS T GVSGL PSTGV S GLPGT SGLPG T -----
NBHUA2 (P) ----V T LSPKD [77] Leucine rich alpha 2 gp -human LPHUC3 (P) PEVRP T SAVAA [78] apolipoprotein C-III -human KQHU (P) QFVHV S ESFPH [79] tissue kallikrein PGFNM S LLENH -human EPENF S FPDDL HEMO_HUMAN (S) -----T PLPPT [77] hemopexin -human BOHUS (P) RPVLP T QSAHD [80] sex steroid binding protein -human HCHU (P) -GPVP T PPDNI [81, 82] a-1-microglobulin QEEEG S GGGQL MBBOB (PIR) IVTPR T PPPSQ [83] myelin basic protein -bovineNEAVP T PVVDP -human TVVQP S VGAAA ITHUC1 (P) GKVAT T VISKM [87, 88] complement ILEVS S LPTTN C1 inhibitor PTTNS T TNSAT -human ITANT T DEPTT TDEPT T QPTTE TTQPT T EPTTQ TTEPT T QPTIQ LITH_HUMAN (S) -PEAQ T ELPQA [89] lithostathine -human APE_HUMAN (S) RVRAA T VGSLA [90] apolipoprotein E -human JXHU (P) ERLAG T ESPVR [91, 92] transferrin receptor -human IVHUA2 (S) QGVGV T ETPLM [93] interferon a2 -human TNFB_HUMAN (S) PGVGL T PSAAQ [94] lymphotoxin (TNF) MMMSND (P) DYDLV T SHLGL [95] nidogen VPRIL S PGYEA -mouse PGYEA T ERPRG PRGVP T ERTRS VPTER T RSFQL PPCLS T VAPPI GPVVP T AVIPL A25093 (P) PALQP T QGAMP [96] granulocyte colony stim. f. -human ENV_MLVFR (S) PVSNS T PTMIS [97] knob protein TPTMI S PSPTP gp71 -mouse TMISP S PTPTQ ISPSP T PTQPP PSPTP T QPPPA QALNL T NPDKT TNPDK T QECWL IL5_HUMAN (S) ---IP T EIPTS [98] interleukin 5 -human IGHU2 (P) VSTPP T VLPDN [99] insulinITAB_HUMAN (S) DWGLP S PSPSP [102] platelet M. PSPSP S PIHPA glycoprotein IIB GLP_MACFU (S) ----S S TTVPA [103] glycophorin ---SS T TVPAT macaca --SST T VPATH fuscata
TTVPA T HTSSS VPATH T SSSSL PATHT S SSSLG ATHTS S SSLGP THTSS S SLGPE HTSSS S LGPEQ PEQYV S SQSND EQYVS S QSNDK SNDKH T SDSHP SDSHP T PTSAH SHPTP T SAHEV SAHEV T TEFSG AHEVT T EFSGR VTTEF S GRTHY EFSGR T HYPPE
